{"id":2895,"company":{"country":"US","currency":"USD","exchange":"NASDAQ NMS - GLOBAL MARKET","ipo":"2019-03-28","marketCap":48.726890563964844,"name":"Precision BioSciences Inc","phone":"19193145512","outstanding":121.91999816894531,"symbol":"DTIL","website":"https://precisionbiosciences.com/","industry":"Biotechnology"},"price":11.5635,"year":2024,"month":2,"day":15,"weekday":"Thursday","title":"The Role of Precision BioSciences Inc Stock in a Diversified Investment Portfolio","date":"2024-02-15","url":"/posts/2024/02/15/DTIL","content":[{"section":"Introduction","text":"Precision BioSciences Inc is a biotechnology company that develops gene editing technologies and therapies. Investing in their stock can provide investors with exposure to the rapidly advancing field of biotechnology."},{"section":"Growth Potential","text":"Precision BioSciences Inc is at the forefront of gene editing research, which has the potential to revolutionize healthcare and various industries. Their technology, known as ARCUS, enables precise and efficient gene edits, offering promising applications in treating genetic diseases, developing targeted cancer therapies, and improving agricultural outputs. As the demand for gene editing solutions grows, Precision BioSciences Inc stock may experience significant growth."},{"section":"Diversification","text":"Including Precision BioSciences Inc stock in a diversified investment portfolio can help spread risk. Allocating a portion of the portfolio to biotechnology companies, such as Precision BioSciences Inc, allows investors to participate in the potential upside of this sector. Diversification helps reduce the impact of any single investment's performance on the overall portfolio."},{"section":"Long-Term Perspective","text":"Investing in Precision BioSciences Inc stock requires a long-term perspective. Biotechnology breakthroughs often take time to develop, receive regulatory approvals, and commercialize. Therefore, investors should be prepared for potential fluctuations in the stock price over the short term. However, with advancements in gene editing technology and Precision BioSciences Inc's expertise, the stock may have the potential for long-term growth."},{"section":"Risks","text":"Investing in any individual stock carries risks, and Precision BioSciences Inc stock is no exception. The biotechnology sector is subject to regulatory approvals, clinical trial outcomes, and market dynamics. Changes in regulations or competition can impact the stock's performance. It's important to evaluate one's risk tolerance and diversify across different sectors and asset classes to mitigate these risks."},{"section":"Conclusion","text":"In conclusion, Precision BioSciences Inc stock can provide an opportunity for potential growth and diversification in a diversified investment portfolio. As a leading gene editing company, Precision BioSciences Inc's technological advancements and potential applications in healthcare and agriculture make it an attractive addition to a well-rounded investment portfolio. However, it's essential to consider the associated risks and approach the investment with a long-term perspective."}],"tags":["CrossOver21","Long","Biotechnology"],"news":[{"category":"company","date":1707912000,"headline":"Precision BioSciences Receives Pre-IND Feedback from US FDA for PBGENE-HBV as it Advances Towards Clinical Readiness","id":125861856,"image":"https://media.zenfs.com/en/business-wire.com/d134f3f3b7ff516c841a76c1a27c0e63","symbol":"DTIL","publisher":"Yahoo","summary":"DURHAM, N.C., February 14, 2024--Precision BioSciences, Inc. (Nasdaq: DTIL), an advanced gene editing company utilizing its novel proprietary ARCUS® platform to develop in vivo gene editing therapies for sophisticated gene edits, including gene insertion, excision, and elimination, today announced that the company has received pre-IND regulatory feedback from the U.S. Food and Drug Administration (FDA) and ex-U.S. agencies. Receipt of this regulatory feedback provides alignment and clarity on Pr","url":"https://finance.yahoo.com/news/precision-biosciences-receives-pre-ind-120000584.html"},{"category":"company","date":1707897360,"headline":"Buy Rating Affirmed for Precision BioSciences Amid Progress in HBV Gene Therapy Program","id":125865928,"image":"","symbol":"DTIL","publisher":"TipRanks","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3349323350"},{"category":"company","date":1707825600,"headline":"Precision BioSciences Promotes Naresh Tanna to Vice President of Investor Relations","id":125848091,"image":"https://media.zenfs.com/en/business-wire.com/1c90bfeb9d03c951bcc512a0650b3ed7","symbol":"DTIL","publisher":"Yahoo","summary":"DURHAM, N.C., February 13, 2024--Precision BioSciences, Inc. (Nasdaq: DTIL), an advanced gene editing company utilizing its novel proprietary ARCUS® platform to develop in vivo gene editing therapies for sophisticated gene edits, including gene elimination, insertion, and excision, today announced that Naresh Tanna, Chief of Staff to the CEO, has been promoted to Vice President of Investor Relations to enhance and expand its IR program and communications with shareholders.","url":"https://finance.yahoo.com/news/precision-biosciences-promotes-naresh-tanna-120000726.html"},{"category":"company","date":1707810180,"headline":"Precision BioSciences Executes 1-for-30 Reverse Stock Split","id":125831477,"image":"","symbol":"DTIL","publisher":"TipRanks","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3347416902"},{"category":"company","date":1707807000,"headline":"Precision BioSciences trading halted, news pending","id":125865932,"image":"","symbol":"DTIL","publisher":"Thefly.com","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3348418041"},{"category":"company","date":1707739200,"headline":"Precision BioSciences Receives Initial $7.5 Million Cash Payment and Equity Investment from TG Therapeutics for Azel-Cel in Treatment of Autoimmune Diseases","id":125810365,"image":"https://media.zenfs.com/en/business-wire.com/a6886b49b7cf9c1ae728194428fb9286","symbol":"DTIL","publisher":"Yahoo","summary":"DURHAM, N.C., February 12, 2024--Precision BioSciences, Inc. (Nasdaq: DTIL), an advanced gene editing company utilizing its novel proprietary ARCUS® platform to develop in vivo gene editing therapies for sophisticated gene edits, including gene elimination, insertion, and excision, today received an upfront cash payment and equity investment from TG Therapeutics, Inc. (Nasdaq: TGTX) for an exclusive license to develop Azercabtagene Zapreleucel (azer-cel) for autoimmune diseases, and other indica","url":"https://finance.yahoo.com/news/precision-biosciences-receives-initial-7-120000393.html"},{"category":"company","date":1707718320,"headline":"Precision gets initial $7.5M from TG Therapeutics for azer-cel development","id":125801083,"image":"","symbol":"DTIL","publisher":"Thefly.com","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3345567752"},{"category":"company","date":1707480000,"headline":"Precision BioSciences to Effect a Reverse Stock Split","id":125714838,"image":"https://media.zenfs.com/en/business-wire.com/20bb4de7956a48e911d46d154bb221cd","symbol":"DTIL","publisher":"Yahoo","summary":"DURHAM, N.C., February 09, 2024--Precision BioSciences, Inc. (Nasdaq: DTIL), an advanced gene editing company utilizing its novel proprietary ARCUS® platform to develop in vivo gene editing therapies for sophisticated gene edits, including gene elimination, insertion, and excision, today announced that its Board of Directors has approved a 1-for-30 reverse stock split of the Company’s common stock. The reverse stock split will become effective at 5:00 p.m. Eastern Time on February 13, 2024, afte","url":"https://finance.yahoo.com/news/precision-biosciences-effect-reverse-stock-120000382.html"},{"category":"company","date":1707461160,"headline":"Precision Biosciences to execute reverse stock split","id":125734791,"image":"","symbol":"DTIL","publisher":"Seeking Alpha","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3341683066"},{"category":"company","date":1707189780,"headline":"Precision BioSciences Inc at H.C. Wainwright \u0026 Co LLC 4th Annual Hepatitis B Virus (HBV) ...","id":125600130,"image":"","symbol":"DTIL","publisher":"GuruFocus","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3336192202"},{"category":"company","date":1707189780,"headline":"Precision BioSciences Inc at Stifel Tailoring Genes: Genetic Medicines Day (Virtual) Transcript","id":125600125,"image":"","symbol":"DTIL","publisher":"GuruFocus","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3336192203"},{"category":"company","date":1707189780,"headline":"Precision BioSciences Inc Annual Shareholders Meeting Transcript","id":125600123,"image":"","symbol":"DTIL","publisher":"GuruFocus","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3336192204"},{"category":"company","date":1707189780,"headline":"Precision BioSciences Inc at Guggenheim Healthcare Talks: Genomic Medicines and Rare Disease ...","id":125600122,"image":"","symbol":"DTIL","publisher":"GuruFocus","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3336192205"},{"category":"company","date":1707189780,"headline":"Precision BioSciences Inc at HC Wainwright Cell Therapy Virtual Conference Transcript","id":125600121,"image":"","symbol":"DTIL","publisher":"GuruFocus","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3336192206"},{"category":"company","date":1707189780,"headline":"Precision BioSciences Inc at H C Wainwright Global Investment Conference (Virtual) Transcript","id":125600120,"image":"","symbol":"DTIL","publisher":"GuruFocus","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3336192207"},{"category":"company","date":1707189780,"headline":"Precision BioSciences Inc Announces In Vivo Gene Editing Collaboration with Novatris Transcript","id":125600118,"image":"","symbol":"DTIL","publisher":"GuruFocus","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3336192208"},{"category":"company","date":1707189780,"headline":"Precision BioSciences Inc Allogeneic CAR T Update- Conference Call Transcript","id":125600117,"image":"","symbol":"DTIL","publisher":"GuruFocus","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3336192209"},{"category":"company","date":1707189780,"headline":"Precision BioSciences Inc at Jefferies Gene Therapy/Editing Summit (Virtual) Transcript","id":125600115,"image":"","symbol":"DTIL","publisher":"GuruFocus","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3336192211"},{"category":"company","date":1707189780,"headline":"Precision BioSciences Inc PBCAR0191 Clinical Data Call Transcript","id":125600113,"image":"","symbol":"DTIL","publisher":"GuruFocus","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3336192212"},{"category":"company","date":1707189780,"headline":"Precision BioSciences Inc Reacquires Global Rights to its Allogeneic CAR T Programs- Conference ...","id":125600111,"image":"","symbol":"DTIL","publisher":"GuruFocus","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3336192214"},{"category":"company","date":1707189780,"headline":"Precision BioSciences Inc at Truist Securities Life Sciences Summit (April Series) Transcript","id":125600110,"image":"","symbol":"DTIL","publisher":"GuruFocus","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3336192215"},{"category":"company","date":1707189780,"headline":"Precision BioSciences Inc at JPMorgan Healthcare Conference (Virtual) Transcript","id":125600109,"image":"","symbol":"DTIL","publisher":"GuruFocus","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3336192216"},{"category":"company","date":1707189780,"headline":"Cell Gene Meeting on the Mesa - Precision BioSciences Transcript","id":125600108,"image":"","symbol":"DTIL","publisher":"GuruFocus","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3336192217"},{"category":"company","date":1707189780,"headline":"Precision BioSciences Inc Interim Data Results for PBCAR0191- Conference Call Transcript","id":125600107,"image":"","symbol":"DTIL","publisher":"GuruFocus","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3336192218"},{"category":"company","date":1707189780,"headline":"Precision BioSciences Inc and Eli Lilly and Co In Vivo Gene Editing Collaboration - Conference ...","id":125600106,"image":"","symbol":"DTIL","publisher":"GuruFocus","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3336192219"},{"category":"company","date":1707189780,"headline":"Precision BioSciences Inc Extraordinary Shareholders Meeting Transcript","id":125600104,"image":"","symbol":"DTIL","publisher":"GuruFocus","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3336192201"}]}